WHOOP's new high-end fitness tracker is just straight-up dying all over the place
TL;DR WHOOP introduced its 5.0 and MG trackers earlier this month.
A concerning number of new WHOOP MG owners have been posting about the trackers failing within hours of first use.
This very public failure follows hot on the heels of WHOOP criticism for backing down from earlier upgrade promises.
Earlier this month, WHOOP introduced its latest fitness trackers, announcing the WHOOP 5.0 and WHOOP Medical Grade (MG). The company's screen-less solutions offer an alternative to wearables that demand a lot of user attention, so long as you're cool with the subscription-based model they require. While everything sounded fine initially, it didn't take too long for the first sign of trouble to creep up, as existing users started complaining about being charged to upgrade to the new hardware, despite earlier promises of getting it for free. As if that weren't trouble enough, today we're leaning about yet another dark cloud casting itself over the recent launch.
Compared to the WHOOP 5.0, the WHOOP MG and its corresponding 'Life' subscription tier offer advanced health features like atrial fibrillation (AFib) detection, blood pressure insights, and a heart screener with electrocardiogram (ECG). Understandably, a lot of the company's users found that MG option particularly appealing, and signed up right away. But it took basically no time at all before reports of problems started piling up.
The crew over at Tech Issues Today has been compiling some of these user complaints, and there is absolutely no shortage of them. We hear in multiple Reddit threads, like these from users Kingmasala, SalesRep44, and ivanflo, that their brand-new trackers are just straight-up dying, either right out of the gate or within the first day or so of operation.
Some users, like Mountain-Lead, have shared communication they've received from WHOOP where the company says it's proactively sending our replacement hardware, suggesting awareness of a widespread issue. Frustratingly, some seem to be getting the wrong devices, receiving the base WHOOP 5.0 instead of a direct replacement for the pricier WHOOP MG.
If you're experiencing issues with your WHOOP tracker, the company offers some troubleshooting steps you can attempt, but you may ultimately need to contact support for a replacement. Just keep your fingers crossed that you get the right one sent to you, we guess.
Got a tip? Talk to us! Email our staff at
Email our staff at news@androidauthority.com . You can stay anonymous or get credit for the info, it's your choice.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
FACT FOCUS: RFK Jr.'s reasons for cutting mRNA vaccine not supported by evidence
Although mRNA vaccines saved millions of lives during the COVID-19 pandemic, U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued they are ineffective to justify the Department of Health and Human Service's recent decision to cancel $500 million in government-funded research projects to develop new vaccines using the technology. The longtime vaccine critic said in an X video posted Tuesday evening that mRNA vaccines do not adequately prevent upper respiratory infections such as COVID-19 and the flu, advocating instead for the development vaccines that use other processes. COVID-19 is the only virus for which real-world data on mRNA vaccine effectiveness is currently available, as mRNA vaccines for other diseases, including the flu, are still under development. The two scientists whose discoveries enabled the creation of mRNA vaccines against COVID-19 won a Nobel Prize in 2023 for their work. Kennedy's claim ignores how mRNA vaccines work, according to experts. They prevent against severe infection and death, but cannot completely prevent an infection from occurring in the first place. Plus, years of research supports the effectiveness of COVID-19 vaccines that use mRNA technology. Here's a closer look at the facts. KENNEDY: 'As the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract.' THE FACTS: His claim is contradicted by scientific evidence. Countless studies show that vaccinated individuals fare far better against COVID-19 infections than those who are unvaccinated, while others have estimated that COVID-19 vaccines prevented millions of deaths during the global pandemic. The mRNA vaccines do not prevent respiratory diseases entirely, experts say. Rather, they can prevent more serious illness that leads to complications and death. For example, an mRNA vaccine against COVID-19 may prevent an infection in the upper respiratory tract that feels like a bad cold from spreading to the lower respiratory tract, where it could affect one's ability to breathe. 'A vaccine cannot block a respiratory infection,' said Dr. Jake Scott, an infectious diseases physician and clinical associate professor at Stanford University School of Medicine. 'That's never been the standard for a respiratory virus vaccine. And it's never been the expectation, and it's never been that realistic.' He called Kennedy's claim 'misguided.' Jeff Coller, a professor of RNA biology and therapeutics at Johns Hopkins University, had a similar outlook. 'Vaccinations don't have to be neutralizing, meaning that you're not going to get COVID,' he said. 'But the important part of a vaccination is that they reduce hospitalization and death. And a reduction in hospitalization and death is proof of an effective vaccine.' Vaccines have traditionally required growing viruses or pieces of viruses called proteins and then purifying them. Then a small dose of the vaccine is injected to train the body how to recognize when a real infection hits so it's ready to fight back. But this method takes a long time. The mRNA technology speeds up the process and allows existing vaccines to be updated more quickly. The 'm' in mRNA stands for messenger because the vaccine carries instructions for our bodies to make proteins. Scientists figured out how to harness that natural process for vaccines by making mRNA in a lab. They take a snippet of the genetic code that carries instructions for making the protein they want the vaccine to target. Injecting that snippet instructs the body to become its own mini-vaccine factory, making enough copies of the protein for the immune system to recognize and react. Scott explained that mRNA vaccines are not a 'magic force field' that the immune system can use to block an infection, as it can't detect whether a virus is nearby. It can only respond to a virus that has already entered the body. In the case of COVID-19, this means that the virus could cause an upper respiratory tract infection — a cold, essentially — but would be significantly less likely to cause more severe consequences elsewhere. Myriad studies on the effectiveness of COVID-19 vaccines have been published since they first became available in late 2020. Although protection does wane over time, they provide the strongest barrier against severe infection and death. For example, a 2024 study by the World Health Organization found COVID-19 vaccines reduced deaths in the WHO's European region by at least 57%, saving more than 1.4 million lives since their introduction in December 2020. A 2022 study published in the journal Lancet Infectious Diseases found that nearly 20 million lives were saved by COVID-19 vaccines during their first year. Researchers used data from 185 countries to estimate that vaccines prevented 4.2 million COVID-19 deaths in India, 1.9 million in the United States, 1 million in Brazil, 631,000 in France and 507,000 in the United Kingdom. The main finding — that 19.8 million COVID-19 deaths were prevented — is based on estimates of how many more deaths than usual occurred during the time period. Using only reported COVID-19 deaths, the same model yielded 14.4 million deaths averted by vaccines. Another 2022 study, published in The New England Journal of Medicine, reported that two mRNA vaccines were more than 90% effective against COVID-19. Operation Warp Speed, the federal effort to facilitate the development and distribution of a COVID-19 vaccine, began under the first Trump administration. 'What I don't understand is why is President Trump is allowing RFK Jr. to undermine his legacy that led to a medical intervention that literally saved millions of lives?' Coller said. 'Why is Trump allowing RFK to undermine U.S. leadership in biomedical research and drug development?' ___ Find AP Fact Checks here: Solve the daily Crossword
Yahoo
16 minutes ago
- Yahoo
Waabi introduces mixed reality testing system for autonomous truck safety
Waabi, an autonomous trucking technology leader, has introduced a new mixed reality testing (MRT) system that transforms the way autonomous vehicles are tested. The technology works by blending physical test environments with sophisticated virtual scenarios. In an interview with FreightWaves, Raquel Urtasun, founder and CEO of Waabi, recently talked about how this technology creates virtual scenarios for autonomous trucks operating on physical test tracks. 'In the industry, we often talk about driving in the physical world as one type of testing, and we also discuss simulation, where we run scenarios in the cloud at scale,' said Urtasun. 'But one aspect that's discussed less is how safety testing is really done today, and that's where mixed reality comes in.' Traditional safety testing for vehicles has remained largely unchanged for a century. Testing teams bring vehicles to closed tracks and conduct a limited number of scripted scenarios that require complex coordination similar to movie stunts. A downside to this approach is that it yields minimal test diversity, offers poor repeatability and avoids truly dangerous scenarios to prevent damage to test vehicles. It's also expensive. Waabi's MRT system overcomes these limitations by intercepting sensor data from the physical world and blending it with simulation. This creates an environment where autonomous trucks can safely encounter virtually unlimited dangerous situations without physical risk. 'Imagine putting goggles on a self-driving vehicle so it sees things that aren't there but reacts to them,' Urtasun explained. 'Suddenly, you can expose the system to unavoidable accidents and scenarios impossible to stage safely in the real world.' In a blog post, Waabi adds that the technology enables instantaneous creation of complex scenarios including traffic jams, dangerous driving behaviors and unpredictable pedestrian movements. The secret sauce is the use of generative AI and neural simulations rather than traditional physics-based simulation to achieve the required level of realism. This allows Waabi to create thousands of tests as vehicles drive continuously on a test track, generating precise performance metrics automatically. This technology has significantly accelerated Waabi's development process as the company reached feature-complete status earlier this year. Waabi's autonomous system now has all capabilities needed to operate without a human driver. Only Waabi and Aurora have reached this milestone in long-haul trucking. These developments come as Waabi announced back in February a strategic partnership with Volvo Autonomous Solutions to jointly develop and deploy autonomous trucks. To date, Toronto-based Waabi has raised a total of $280 million, with its most recent round, a $200 million Series B back in 2024, including participation from strategic investors Nvidia, Volvo Group Venture Capital, Porsche Automobil Holding SE, Scania Invest and Ingka Investments, among others. The post Waabi introduces mixed reality testing system for autonomous truck safety appeared first on FreightWaves.
Yahoo
16 minutes ago
- Yahoo
Rivian, Lucid Brace for a Rough Ride as EV Headwinds Intensify
Rivian (RIVN, Financials) and Lucid Group (LCID, Financials) are warning that the rest of 2025 will be bumpy; policy changes, trade tensions and supply?chain snags are putting pressure on electric?vehicle makers. Rivian shares slid about 4% after hours; Lucid fell roughly 7%. Warning! GuruFocus has detected 5 Warning Signs with RIVN. The Trump administration has reshaped the EV landscape ending consumer tax credits; imposing steep tariffs on imported auto parts; and scrapping emission fines for gas?vehicle makers. China's tighter export limits on heavy rare earth metals critical for EV motors have only made things worse; supply chains are straining under the weight. For Rivian, that's meant higher costs and shrinking side income from selling regulatory credits. The company now expects a deeper adjusted core loss of $2 billion to $2.25 billion this year; that's up from its prior $1.7 billion to $1.9 billion range. Per?unit costs jumped 8% to about $118,375; lower production added roughly $14,000 per vehicle. A three?week production pause in September will prepare its lower?priced R2 SUV for a 2026 launch; management says the model is key to reaching a wider audience. Lucid avoided the worst of the rare?earth crunch by tapping into existing magnet inventory; still, tariffs have eaten into margins. The luxury EV maker cut its annual production goal; it also warned of softer demand in Q4 once the $7,500 federal tax credit expires at the end of September. Analysts expect a rush of Q3 sales as buyers race to lock in the incentive; the risk is that the pull?forward leaves a hole later in the year. This article first appeared on GuruFocus.
